Grimstad Frances, Krieg Sacha
Department of Obstetrics and Gynecology, University of Kansas, 3901 Rainbow Blvd MS 2028, Kansas City, KS, 66160, USA.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Oregon Health Sciences University, Portland, OR, USA.
J Assist Reprod Genet. 2016 Jul;33(7):833-47. doi: 10.1007/s10815-016-0720-6. Epub 2016 May 12.
While sporadic pregnancy loss is common, occurring in 15 % of pregnancies, recurrent pregnancy loss (RPL) impacts approximately 5 % of couples. Though multiple causes are known (including structural, hormonal, infectious, autoimmune, and thrombophilic causes), after evaluation, roughly half of all cases remain unexplained. The idiopathic RPL cases pose a challenging therapeutic dilemma in addition to incurring much physical and emotional morbidity. Immunogenetic causes have been postulated to contribute to these cases of RPL. Natural Killer cell, T cell expression pattern changes in the endometrium have both been shown in patients with RPL. Human leukocyte antigen (HLA) and cytokine allelic variations have also been studied as etiologies for RPL. Some of the results have been promising, however the studies are small and have not yet put forth outcomes that would change our current diagnosis and management of RPL. Larger database studies are needed with stricter control criteria before reasonable conclusions can be drawn.
虽然散发性流产很常见,在15%的妊娠中都会发生,但复发性流产(RPL)影响着约5%的夫妇。尽管已知多种病因(包括结构、激素、感染、自身免疫和血栓形成原因),但经过评估后,大约一半的病例仍无法解释。特发性RPL病例除了会导致大量身心疾病外,还带来了具有挑战性的治疗困境。免疫遗传学原因被认为与这些RPL病例有关。RPL患者的子宫内膜中自然杀伤细胞和T细胞表达模式均发生了变化。人类白细胞抗原(HLA)和细胞因子等位基因变异也已作为RPL的病因进行了研究。一些结果很有前景,然而这些研究规模较小,尚未得出能改变我们目前对RPL诊断和管理的结果。在得出合理结论之前,需要进行更严格对照标准的更大规模数据库研究。